Prevalence of BRCA1 and BRCA2 Mutations in Ovarian Cancer Patients in the Gulf Region
NCT03082976
·
clinicaltrials.gov ↗
COMPLETED
Status
108
Enrollment
INDUSTRY
Sponsor class
Conditions
Ovarian Cancer
Sponsor
AstraZeneca